Cas:223132-37-4 Inolitazone manufacturer & supplier

Chemical Name:Inolitazone

CAS.NO:223132-37-4

Synonyms:Inolitazone;Efatutazone;5-(4-{[5-(4-Amino-3,5-dimethylphenoxy)-1H-benzimidazol-2-yl]methoxy}benzyl)-1,3-thiazolidine-2,4-dione;UNII-M17ILL71MC;2,4-Thiazolidinedione, 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-

Molecular Formula:C₂₇H₂₆N₄O₄S

Molecular Weight:502.58

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:794.6±60.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.706

PSA:144.63000

Exact Mass:

LogP:3.61

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Inolitazone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Thiazolidinedione, 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,UNII-M17ILL71MC Use and application,2,4-Thiazolidinedione, 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]- technical grade,usp/ep/jp grade.

Related News: The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). Inolitazone manufacturer The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. Inolitazone supplier International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. Inolitazone vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. Inolitazone factory The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.